{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03383081",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SCLnow-XY-02"
      },
      "Organization": {
        "OrgFullName": "Sclnow Biotechnology Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis",
      "OfficialTitle": "A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 1, 2018",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 12, 2017",
      "StudyFirstSubmitQCDate": "December 21, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 26, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 21, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 23, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Sclnow Biotechnology Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease",
      "DetailedDescription": "This is a random, open label, and parallel controled experiment. All patients are selected and sign consent forms, then divided into 3 groups. Doctors collect the basic information of patient. All patients receive laboratory and image examination as baseline. Then, they will give cell treatment based on the clinical protocol. Doctors have follow-up visit on 2 weeks, 1, 2, 3, 6, and 12 months after treatment, and do safety and efficacy evaluation.\n\nSafety evaluation. Researcher collect all examination data of patients and compare with each groups. The safety tests including blood routine, urine routine, hepatorenal function, C reactive protein, erythrocyte sedimentation rate, and tumor marker, etc.\n\nEfficacy evaluation. Based on Lysholm, the international knee documentation committee (IKDC) knee evaluation form, and Visual Analogue Scale/Score (VAS) to examine the change/improvement of knee joint function. By Magnetic Resonance Imaging (MRI) examination, grade patients with Kellgren-Lawrence Grading Scale, Assessment of Preoperative Cartilage Defect Severity (AMADEUS), and observe the change/improvement of patient."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteoarthritis, Knee"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "osteoarthritis, mesenchymal stem cell"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "60",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Low dose mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Low dose group: intra-articular injection with human umbilical cord mesenchymal stem cells (SCLnow 19#)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Low dose mesenchymal stem cells",
                "Procedure: Intraarticular injection"
              ]
            }
          },
          {
            "ArmGroupLabel": "High dose mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "High dose group: intra-articular injection with human umbilical cord mesenchymal stem cells (SCLnow 19#)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: High dose mesenchymal stem cells",
                "Procedure: Intraarticular injection"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control groups",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "No intervention"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Low dose mesenchymal stem cells",
            "InterventionDescription": "Human umbilical cord mesenchymal stem cells (SCLnow 19#): group A, 1 * 10^7 cells (5ml);",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Low dose mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "High dose mesenchymal stem cells",
            "InterventionDescription": "Human umbilical cord mesenchymal stem cells (SCLnow 19#): group B, 2 * 10^7 cells (5ml)",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "High dose mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "Intraarticular injection",
            "InterventionDescription": "Intraarticular injection with human umbilical cord mesenchymal stem cells (SCLnow 19#) with different dose group",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "High dose mesenchymal stem cells",
                "Low dose mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Kellgren-Lawrence Grading Scale",
            "PrimaryOutcomeDescription": "Using Magnetic Resonance Imaging (MRI) examination, and based on the images of bilateral knee joint, grade by Kellgren-Lawrence Grading Scale. Kellgren-Lawrence Grading Scale is a method of classifying the severity of knee osteoarthritis (OA).\n\nGrade 0: No radiographic features of osteoarthritis; Grade 1: Possible joint space narrowing (normal joint space is at least 2 mm at the superior acetabulum) and osteophyte formation; Grade 2: Definite osteophyte formation with possible joint space narrowing; Grade 3: Multiple osteophytes, definite joint space narrowing, sclerosis and possible bony deformity; Grade 4: Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony deformity.",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Assessment of Preoperative Cartilage Defect Severity (AMADEUS)",
            "SecondaryOutcomeDescription": "Using Magnetic Resonance Imaging (MRI) examination to diagnose patients by Assessment of Preoperative Cartilage Defect Severity (AMADEUS).",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Lysholm scoring",
            "SecondaryOutcomeDescription": "Using Lysholm Knee Scoring Scale to grade the knee function of patients, and examine the changes or improvement compare to baseline.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "The international knee documentation committee (IKDC) knee evaluation form",
            "SecondaryOutcomeDescription": "The international knee documentation committee knee evaluation form is used to assess the knee function of patients, examine the changes or improvement compare to baseline.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Visual Analogue Scale/Score（VAS）",
            "SecondaryOutcomeDescription": "Using Visual Analogue Scale/Score for pain to examine the change/improvement of knee joint function.",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of Knee Osteoarthritis by Kellgren and Lawrence Grading Scale, classified with Grade 2-3\nConfirm with cartilage injury,articular cartilage part or full-thickness injury, by MR (Magnetic Resonance)\nAge <70, no serious organ dysfunction\nOver 2 years knee pain or no very effective with conservative treatments\nKnee pain of VAS (visual analog scale score) is 4 or higher\nNormal hepatic and renal function, no history of gout, rheumatoid arthritis, and autoimmune diseases, etc.\nUnderstand and sign the consent form of this study\n\nExclusion Criteria:\n\nRefuse to sign the consent form, or cannot keep follow-up visit\nAge >70; Age <70, but with multiple organ failure\nUnstable vital signs (breath, blood pressure, pulse)\nCombined with knee ligament (anterior and the posterior cruciate ligament, medial and lateral collateral ligament) rupture, laxity, etc.\nSerious bleeding tendency, poor coagulation function (PTA <35%)\nPregnant or breast feeding women, or positive pregnancy test in 7 days before treatment\nParticipate other clinical experiments in 3 months\nWith progressing malignant tumor\nCombined with shock and critically ill patients\nWith mental disease, cannot\nWith history of knee joint infection, surgery, and radiotherapy\nWith immunosuppressive agents treatment in 6 weeks\nInjection with hormones and sodium hyaluronate in joint in 3 months\nOverweight expressed as body mass index (BMI) >35\nWith skin disease around knee joint\nWith Immunodeficiency disease, including long term use immunosuppressive agents patients\nCombined with serious infection\nWith some other conditions that doctor propose not to participate",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Lei Guo",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "861064368977",
            "CentralContactEMail": "georgeguo@sclnow.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Hongbin Lv",
            "OverallOfficialAffiliation": "Xiangya Hospital of Central South University",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Xiangya Hospital Central South University",
            "LocationStatus": "Recruiting",
            "LocationCity": "Changsha",
            "LocationState": "Hunan",
            "LocationZip": "410008",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Hongbin Lyu",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "13126966160",
                  "LocationContactEMail": "michaelliang@sclnow.com"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Osteoarthritis, Knee",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}